CytomX reported a quarterly loss of $0.22 per share versus the Zacks consensus loss of $0.08, missing by $0.14. This compares with earnings of $0.22 per share a year ago, a year-over-year swing of $0.44, signaling a material deterioration in profitability and likely negative near-term investor reaction.
CytomX reported a quarterly loss of $0.22 per share versus the Zacks consensus loss of $0.08, missing by $0.14. This compares with earnings of $0.22 per share a year ago, a year-over-year swing of $0.44, signaling a material deterioration in profitability and likely negative near-term investor reaction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment
